These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C, Sunderkötter C, Kaatz M, Schulte KW, Lehmann P, Vogt T, Ulrich J, Herbst R, Gehring W, Simon JC, Keim U, Martus P, Garbe C, German Dermatologic Cooperative Oncology Group (DeCOG). Lancet Oncol; 2016 Jun 28; 17(6):757-767. PubMed ID: 27161539 [Abstract] [Full Text] [Related]
4. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB, MSLT Group. N Engl J Med; 2014 Feb 13; 370(7):599-609. PubMed ID: 24521106 [Abstract] [Full Text] [Related]
5. Radical dissection after positive groin sentinel biopsy in melanoma patients: rate of further positive nodes. Santinami M, Carbone A, Crippa F, Maurichi A, Pellitteri C, Ruggeri R, Zoras O, Patuzzo R. Melanoma Res; 2009 Apr 13; 19(2):112-8. PubMed ID: 19282788 [Abstract] [Full Text] [Related]
6. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma. Kyrgidis A, Tzellos T, Mocellin S, Apalla Z, Lallas A, Pilati P, Stratigos A. Cochrane Database Syst Rev; 2015 May 16; 2015(5):CD010307. PubMed ID: 25978975 [Abstract] [Full Text] [Related]
7. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma. Bartlett EK, Lee AY, Spanheimer PM, Bello DM, Brady MS, Ariyan CE, Coit DG. Br J Surg; 2020 Oct 16; 107(11):1480-1488. PubMed ID: 32484242 [Abstract] [Full Text] [Related]
10. Completion Lymph Node Dissection or Observation for Melanoma Sentinel Lymph Node Metastases: A Decision Analysis. Burke EE, Portschy PR, Tuttle TM, Kuntz KM. Ann Surg Oncol; 2016 Sep 16; 23(9):2772-8. PubMed ID: 27194553 [Abstract] [Full Text] [Related]
11. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial]. Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G. Orv Hetil; 2013 Dec 08; 154(49):1934-42. PubMed ID: 24292111 [Abstract] [Full Text] [Related]
12. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma. Lee DY, Lau BJ, Huynh KT, Flaherty DC, Lee JH, Stern SL, O'Day SJ, Foshag LJ, Faries MB. J Am Coll Surg; 2016 Jul 08; 223(1):9-18. PubMed ID: 27236435 [Abstract] [Full Text] [Related]
13. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E. Ann Surg Oncol; 2007 Dec 08; 14(12):3566-74. PubMed ID: 17924169 [Abstract] [Full Text] [Related]
14. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Burmeister BH, Henderson MA, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S, Coventry BJ, Babington S, Duprat J, Hoekstra HJ, Thompson JF. Lancet Oncol; 2012 Jun 08; 13(6):589-97. PubMed ID: 22575589 [Abstract] [Full Text] [Related]
17. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial. Multicenter Selective Lymphadenectomy Trials Study Group, Crystal JS, Thompson JF, Hyngstrom J, Caracò C, Zager JS, Jahkola T, Bowles TL, Pennacchioli E, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, van Akkooi A, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Neves RI, Rossi CR, Kane JM, Trocha S, Wright F, Byrd DR, Matter M, Hsueh EC, MacKenzie-Ross A, Kelley M, Terheyden P, Huston TL, Wayne JD, Neuman H, Smithers BM, Ariyan CE, Desai D, Gershenwald JE, Schneebaum S, Gesierich A, Jacobs LK, Lewis JM, McMasters KM, O'Donoghue C, van der Westhuizen A, Sardi A, Barth R, Barone R, McKinnon JG, Slingluff CL, Farma JM, Schultz E, Scheri RP, Vidal-Sicart S, Molina M, Testori AAE, Foshag LJ, Van Kreuningen L, Wang HJ, Sim MS, Scolyer RA, Elashoff DE, Cochran AJ, Faries MB. JAMA Surg; 2022 Sep 01; 157(9):835-842. PubMed ID: 35921122 [Abstract] [Full Text] [Related]
18. Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases. Holtkamp LH, Wang S, Wilmott JS, Madore J, Vilain R, Thompson JF, Nieweg OE, Scolyer RA. Ann Surg Oncol; 2015 Sep 01; 22(9):2972-7. PubMed ID: 25990968 [Abstract] [Full Text] [Related]
19. Time to reconsider the role of sentinel lymph node biopsy in melanoma. Bigby M, Zagarella S, Sladden M, Popescu CM. J Am Acad Dermatol; 2019 Apr 01; 80(4):1168-1171. PubMed ID: 30471314 [Abstract] [Full Text] [Related]
20. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. Cascinelli N, Bombardieri E, Bufalino R, Camerini T, Carbone A, Clemente C, Lenisa L, Mascheroni L, Maurichi A, Pennacchioli E, Patuzzo R, Santinami M, Tragni G. J Clin Oncol; 2006 Sep 20; 24(27):4464-71. PubMed ID: 16983115 [Abstract] [Full Text] [Related] Page: [Next] [New Search]